Product Highlight - MEPRESONE

17 Aug 2022
Product Highlight - MEPRESONE
Step on the brakes of uncontrolled inflammation1
  • Treatment of conditions for which corticosteroid therapy is indicated except adrenocortical-deficiency states, for which hydrocortisone w/ supplementary fludrocortisone is preferred.1

Reference:
1Full prescribing information: Mepresone – The Cathay Drug Co., Inc.


Related MIMS Drugs

Editor's Recommendations